Comparison of Autologous Serum Versus Preservative Free Artificial Tear in Patients with Dry Eyes Due to Systemic Isotretinoin Therapy

References

• Oner AF, Ferahbas A, Karakucuk S, Utas S, Karaman B, Kutlugun C, et al. Ocular side effects associated with systemic isotretinoin. Cutan Ocul Toxicol 2005;23:189–195.
   Web of Science ®Google Scholar
• Egger SF, Huber-Spitzy V, Bohler K, Scholda C. Isotretinoin administration in treatment of acne vulgaris: a prospective study of the kind and extent of ocular complications. Ophthalmologe 1995;92:17–20.
   PubMedGoogle Scholar
• Egger SF, Huber-Spitzy V, Bohler K, Raff M, Scholda C, Barisani T, et al. Ocular side effects associated with 13-cis-retinoic acid therapy for acne vulgaris: clinical features, alterations of tear film and conjunctival flora. Acta Ophthalmol Scand 1995;73:355–357.
   PubMedGoogle Scholar
• Bozkurt B, Irkec¸ MT, Atakan N, Orhan M, Geyik PO. Lacrimal function and ocular complications in patients treated with systemic isotretinoin. Eur J Ophthalmol 2002;12:173–176.
   PubMed Web of Science ®Google Scholar
• Fraunfelder FT, Fraunfelder FW, Edwards R. Ocular side effects possibly associated with isotretinoin usage. Am J Ophthalmol 2001;132:299–305.
   PubMed Web of Science ®Google Scholar
• Fraunfelder FW. Ocular side effects associated with isotretinoin. Drugs Today (Barc) 2004;40:23–27.
   PubMed Web of Science ®Google Scholar
• Neudorfer M, Goldshtein I, Shamai-Lubovitz O, Chodick G, Dadon Y, Shalev V. Ocular adverse effects of systemic treatment with isotretinoin. Arch Dermatol 2012 Jul;148:803–808.
   PubMed Web of Science ®Google Scholar
• Chia EM, Mitchell P, Rochtchina E, Lee AJ, Maroun R, Wang JJ. Prevalence and associations of dry eye syndrome in an older population: the Blue Mountains Eye Study. Clin Exp Ophthalmol 2003;31:229–232.
   PubMed Web of Science ®Google Scholar
• Schaumberg DA, Sullivan DA, Buring JE, Dana MR. Prevalence of dry eye syndrome among US women. Am J Ophthalmol 2003;136:318–326.
   PubMed Web of Science ®Google Scholar
• Lin PY, Tsai SY, Cheng CY, Liu JH, Chou P, Hsu WM. Prevalence of dry eye among an elderly Chinese population in Taiwan: the Shihpai Eye Study. Ophthalmology 2003;110:1096–1101.
   PubMed Web of Science ®Google Scholar
• McCarty CA, Bansal AK, Livingston PM, Stanislavsky YL, Taylor HR. The epidemiology of dry eye in Melbourne, Australia. Ophthalmology 1998;105:1114–1119.
   PubMed Web of Science ®Google Scholar
• Moss SE, Klein R, Klein BE. Prevalence of and risk factors for dry eye syndrome. Arch Ophthalmol 2000;118:1264–1268.
   PubMed Web of Science ®Google Scholar
• Schein OD, Hochberg MC, Muñoz B, Tielsch JM, Bandeen-Roche K, Provost T, et al. Dry eye and dry mouth in the elderly: a population-based assessment. Archiv Int Med 1999;159:1359–1363.
   PubMed Web of Science ®Google Scholar
• The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop. Ocul Surf 2007;5:75–92.
   Google Scholar
• Stern ME, Schaumburg CS, Pflugfelder SC. Dry eye as a mucosal autoimmune disease. Int Rev Immunol 2013;32:19–41.
   PubMed Web of Science ®Google Scholar
• Stevenson W, Chauhan SK, Dana R. Dry eye disease: an immunemediated ocular surface disorder. Arch Ophthalmol 2012;130:90–100.
   PubMed Web of Science ®Google Scholar
• Goyal S, Chauhan SK, Nallasamy N, Zhang Q, Dana R. Evidence of corneal lymphangiogenesis in dry eye disease: a potential link to adaptive immunity? Arch Ophthalmol 2010;128:819–824.
   PubMed Web of Science ®Google Scholar
• Heiligenhaus A, Koch JM, Kruse FE, Schwarz C, Waubke TN. Diagnosis and and differentiation of dry eye disorders]. Diagnostik und Differenzierung von Benetzungsstörungen. Der Ophthalmologe 1995;92:6–11.
   Google Scholar
• Tong L, Chaurasia SS, Mehta JS, Beuerman RW. Screening for meibomian gland disease: its relation to dry eye subtypes and symptoms in a tertiary referral clinic in singapore. Invest Ophthalmol Vis Sci 2010;51:3449–3454.
   PubMed Web of Science ®Google Scholar
• Research Subcommittee of the international Dry Eye Workshop. Research in Dry Eye. Ocul Surf 2007;5:179–193
   Google Scholar
• Ozcura F, Aydin S, Helvaci MR. Ocular surface disease index for the diagnosis of dry eye syndrome. Ocul Immunol Inflamm 2007;15:389–393.
   PubMed Web of Science ®Google Scholar
• Schiffman RM, Christianson MD, Hirsch JD, Reis BL. Reliability and validity of the Ocular Surface Disease Index. Arch Ophthalmol 2000;118:615–621.
   PubMed Web of Science ®Google Scholar
• Matsumoto Y, Dogru M, Goto E Ohashi Y, Kojima T, Ishida R, et al. Autologous serum application in the treatment of neurotrophic keratopathy. Ophthalmology 2004;111:1115–1120.
   Google Scholar
• Vajpayee RB, Mukerji N, Tandon R, Sharma N, Pandey RM, Biswas NR, et al. Evaluation of umbilical cord serum therapy for persistent corneal epithelial defects. Br J Ophthalmol 2003;87:1312–1316.
   PubMed Web of Science ®Google Scholar
• del Castillo JM, de la Casa JM, Sardiña RC, Fernández RM, Feijoo JG, Gómez AC, et al. Treatment ofrecurrent corneal erosions using autologous serum. Cornea2002;21:781–783.
   PubMed Web of Science ®Google Scholar
• Lambert RW, Smith RE. Pathogenesis of blepharoconjunctivitis complicating cis-retinoic acid (isotretinoin) therapy in a laboratory model. Invest OphthalSci 1988;29:1559–1564.
   PubMed Web of Science ®Google Scholar
• Mathers WD, Shields WJ, Sachdev MS, Petroll WM, Jester JV. Meibomian gland morphology and tear osmolarity: changes with accutane therapy. Cornea 1991;10:286–290.
   PubMed Web of Science ®Google Scholar
• Karalezli A, Borazan M, Altinors DD, Dursun R, Kiyici H, Akova YA. Conjunctival impression cytology, ocular surface,and tear film changes in patients treated with systemic isotretinoin. Cornea 2009 Jan;28:46–50.
   PubMed Web of Science ®Google Scholar
• Cumurcu T, Sezer E, Kilic R, Bulut Y. Comparison of dose-related ocular side effects during systemic isotretinoin administration. Eur J Ophthalmol 2009;19:196–200.
   PubMed Web of Science ®Google Scholar
• Yildirim Y, Olcucu O, Agca A, Alagoz C, Demircan A, Basci A, et al. Evaluation of corneal topography and biomechanical parameters after use of systemic isotretinoin in acnevulgaris. J Ophthalmol 2014;2014:701361.
   PubMed Web of Science ®Google Scholar
• Noble BA, Loh RS, MacLennan S Pesudovs K, Reynolds A, Bridges LR, et al. Comparison of autologous serum eye drops with conventional therapy in a randomised controlled crossover trial for ocular surface disease. Br J Ophthalmol 2004;88:647–652.
   PubMed Web of Science ®Google Scholar
• Tananuvat N, Daniell M, Sullivan LJ, Yi Q, McKelvie P, McCarty DJ, et al. Controlled study of the use of autologous serum in dry eye patients. Cornea 2001;20:802–806.
   PubMed Web of Science ®Google Scholar
• Kojima T, Ishida R, Dogru M, Goto E, Matsumoto Y, Kaido M, et al. The effect of autologous serum eyedrops in the treatment of severe dry eye disease: a prospective randomized case-control study. Am J Ophthalmol 2005;139:242–246.
   PubMed Web of Science ®Google Scholar
• Urzua CA, Vasquez DH, Huidobro A, Hernandez H, Alfaro J. Randomized double-blind clinical trial of autologous serum versus artificial tears in dry eye syndrome. Curr Eye Res 2012;37:684–688.
   PubMed Web of Science ®Google Scholar
• Celebi AR, Ulusoy C, Mirza GE. The efficacy of autologous serum eye drops for severe dry eye syndrome: a randomized double-blind crossover study. Graefes Arch Clin Exp Ophthalmol 2014;252:619–626.
   PubMed Web of Science ®Google Scholar
• Hussain M, Shtein RM, Sugar A, Soong HK, Woodward MA, DeLoss K, Mian SI. Long-term use of autologous serum 50% eye drops for the treatment of dry eye disease. Cornea 2014;33:1245–1251.
   PubMed Web of Science ®Google Scholar
• Hwang J, Chung SH, Jeon S, Kwok SK, Park SH, Kim MS. Comparison of clinical efficacies of autologous serum eye drops in patients with primary and secondary Sjögren syndrome. Cornea 2014;33:663–667.
   PubMed Web of Science ®Google Scholar
• Na KS, Kim MS. Allogeneic serum eye drops for the treatment of dry eye patients with chronic graft-versus-host disease. J Ocul Pharmacol Ther 2012;28:479–483. Epub 2012 Jun 25.
   PubMed Web of Science ®Google Scholar
• Semeraro F, Forbice E, Braga O, Bova A, Di Salvatore A, Azzolini C. Evaluation of the efficacy of 50% autologous serum eye drops in different ocular surface pathologies. Biomed Res Int 2014;2014:826970.
   PubMed Web of Science ®Google Scholar